51Cr release assay of antibody-dependent cell-mediated cytotoxicity (ADCC)

Current Protocols in Immunology
D L NelsonD E Serbousek

Abstract

Antibody-dependent cell-mediated cytotoxicity (ADCC) is an immunologic cytotoxic effector mechanism that is dependent on the cooperative interaction of humoral and cellular effector elements. This unit describes an assay of ADCC activity that can be used as a test for immunocompetence in effector cells or to test the activity of a monoclonal antibody to mediate ADCC. In this form of cytotoxicity, effector cells with receptors for the Fc portion of immunoglobulin produce target cell lysis by attachment to the Fc portion of antibodies that are bound to target cells via their antigen-combining sites. Therefore, an ADCC assay involves three essential components: labeled target cells, antibodies with specificity for target-cell surface antigens, and effector-cell populations. The basic protocol describes a method of measuring ADCC effector activity in lymphoid cells (peripheral blood mononuclear cells, or PBMC) that employs (51)Cr-labeled target cells. The three components are mixed in microtiter-plate wells and lysis of the target cells is detected by measuring the release of radioactivity into the cell supernatant. Support protocols describe procedures for preparing anti-target cell antiserum and (51)Cr-labeled target cells.

References

Jan 1, 1992·Advances in Experimental Medicine and Biology·T A WaldmannC Kasten-Sportes
Sep 1, 1990·Blood Reviews·R C Rees
Jun 30, 1983·Annals of the New York Academy of Sciences·M W FangerL Shen
Sep 1, 1980·The American Journal of Tropical Medicine and Hygiene·A CapronJ Pestel

❮ Previous
Next ❯

Citations

Jun 10, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jantine E BakemaMarjolein van Egmond
Jul 3, 2021·Vaccines·Melissa B UccelliniAdolfo García-Sastre

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.